Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schäfer-Korting

Showing results (41-50 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Clinical Pharmacology|January 1, 1985
Human plasma and skin blister fluid levels of griseofulvin after its repeated administrationM Schäfer-Korting, H C Korting, E Mutschler
European Journal of Clinical Pharmacology|January 1, 1985
Human plasma and skin blister fluid levels of griseofulvin following a single oral doseM Schäfer-Korting, H C Korting, E Mutschler
Maturitas|July 26, 2005
Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999Yong Du, Hans-Ulrich Melchert, Monika Schäfer-Korting
European Journal of Clinical Pharmacology|January 1, 1988
The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy manG G Belz, T Meinicke, M Schäfer-Korting
Die Pharmazie|February 26, 1998
Effects of growth factors on the proliferation of human keratinocytes and fibroblasts in vitroD S Kim, H C Korting, M Schäfer-Korting
Die Pharmazie|May 11, 1999
Fusion of the binding domain of Raf-1 kinase with green fluorescent protein for activated Ras detection by fluorescence correlation spectroscopyU Trier, Z Olah, B Kleuser, et al.
Journal of the American Academy of Dermatology|July 1, 1992
Topical glucocorticoids with improved benefit/risk ratio: do they exist?H C Korting, M J Kerscher, M Schäfer-Korting
Toxicology|May 14, 2005
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cellsJudith Sendzik, Mehdi Shakibaei, Monika Schäfer-Korting, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|October 19, 2013
Cytoprotective effects of opioids on irradiated oral epithelial cellsNada Charbaji, Peter Rosenthal, Monika Schäfer-Korting, et al.
Journal of the American Academy of Dermatology|December 1, 1989
Liposome preparations: a step forward in topical drug therapy for skin disease? A reviewM Schäfer-Korting, H C Korting, O Braun-Falco
Pageof 22

Showing results (41-50 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Clinical Pharmacology|January 1, 1985
Human plasma and skin blister fluid levels of griseofulvin after its repeated administrationM Schäfer-Korting, H C Korting, E Mutschler
European Journal of Clinical Pharmacology|January 1, 1985
Human plasma and skin blister fluid levels of griseofulvin following a single oral doseM Schäfer-Korting, H C Korting, E Mutschler
Maturitas|July 26, 2005
Hormone replacement therapy in Germany: determinants and possible health-related outcomes. Results of National Health Surveys from 1984 to 1999Yong Du, Hans-Ulrich Melchert, Monika Schäfer-Korting
European Journal of Clinical Pharmacology|January 1, 1988
The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy manG G Belz, T Meinicke, M Schäfer-Korting
Die Pharmazie|February 26, 1998
Effects of growth factors on the proliferation of human keratinocytes and fibroblasts in vitroD S Kim, H C Korting, M Schäfer-Korting
Die Pharmazie|May 11, 1999
Fusion of the binding domain of Raf-1 kinase with green fluorescent protein for activated Ras detection by fluorescence correlation spectroscopyU Trier, Z Olah, B Kleuser, et al.
Journal of the American Academy of Dermatology|July 1, 1992
Topical glucocorticoids with improved benefit/risk ratio: do they exist?H C Korting, M J Kerscher, M Schäfer-Korting
Toxicology|May 14, 2005
Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cellsJudith Sendzik, Mehdi Shakibaei, Monika Schäfer-Korting, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|October 19, 2013
Cytoprotective effects of opioids on irradiated oral epithelial cellsNada Charbaji, Peter Rosenthal, Monika Schäfer-Korting, et al.
Journal of the American Academy of Dermatology|December 1, 1989
Liposome preparations: a step forward in topical drug therapy for skin disease? A reviewM Schäfer-Korting, H C Korting, O Braun-Falco
Pageof 22